Preloading of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging, NIR-Responsive Drug Release, and Synergistic Therapy.
Applications of hydrophobic drug-based nanocarriers (NCs) remain largely limited because of their low loading capacity. Here, development of a multifunctional hybrid NC made of a magnetic Fe3O4 core and a mesoporous silica shell embedded with carbon dots (CDs) and paclitaxel (PTX), and covered by another layer of silica is reported. The NC is prepared via a one-pot process under mild condition. The PTX loading method introduced in this study simplifies drug loading process and demonstrates a high loading capacity due to mesoporous silica dual-shell structure, supramolecular π-stacking between conjugated rings of PTX molecules, and aromatic rings of the CDs in the hybrid NC. The CDs serve as both confocal and two-photon fluorescence imaging probes, while the Fe3O4 core serves as a magnetic resonance imaging contrast agent. Significantly, NC releases PTX in response to near infrared irradiation as a result of local heating of the embedded CDs and the heating of CDs also provides an additional therapeutic effect by thermally killing cancer cells in tumor in addition to the chemotherapeutic effect of released PTX. Both in vitro and in vivo results show that NC demonstrates high therapeutic efficacy through a synergistic effect from the combined chemo-photothermal treatments.
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Hui
H
Wang
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Kui
K
Wang
Department of Applied Mathematics, University of Washington, Seattle, WA, 98195, USA.
Bowei
B
Tian
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Richard
R
Revia
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Qingxin
Q
Mu
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Mike
M
Jeon
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Fei-Chien
FC
Chang
Department of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Miqin
M
Zhang
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods*; D065546:Drug Liberation; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D051379:Mice; D064847:Multimodal Imaging / Q000379:methods*
D000970:Antineoplastic Agents; D004337:Drug Carriers; D004317:Doxorubicin
hydrophobic drugs; mesoporous silica; multifunctional imaging; preloading; synergistic effects
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
11274893
Nat Mater. 2004 Dec;3(12):891-5
15568032
Nat Rev Cancer. 2005 Jan;5(1):65-72
15630416
Nat Methods. 2005 Dec;2(12):932-40
16299478
Expert Opin Drug Deliv. 2006 May;3(3):311-24
16640493
Cancer. 2006 Aug 1;107(3):459-66
16795065
Small. 2007 Aug;3(8):1341-6
17566138
Toxicol Pathol. 2008 Jan;36(1):43-8
18337220
Adv Drug Deliv Rev. 2008 Jun 10;60(9):979-99
18395291
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-88
18514969
J Nucl Med. 2008 Jun;49 Suppl 2:113S-28S
18523069
Nat Nanotechnol. 2008 May;3(5):284-8
18654525
Biomaterials. 2008 Oct;29(30):4045-55
18675454
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1615-26
18840489
ACS Nano. 2008 May;2(5):889-96
19206485
Small. 2009 Jul;5(14):1637-41
19334014
Adv Drug Deliv Rev. 2010 Mar 8;62(3):362-74
19900497
Chem Rev. 2010 May 12;110(5):3146-95
20225900
Adv Mater. 2010 Oct 8;22(38):4293-7
20564713
ACS Nano. 2010 Oct 26;4(10):6001-13
20815402
Adv Mater. 2010 Dec 7;22(46):5255-9
20972977
Chem Soc Rev. 2012 Apr 7;41(7):2656-72
22189429
Science. 1990 Apr 6;248(4951):73-6
2321027
ACS Nano. 2013 Jul 23;7(7):5965-77
23758167
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2283-8
24474802
ACS Nano. 2014 Apr 22;8(4):3107-22
24641589
Nanoscale. 2014 Jul 7;6(13):7443-52
24881520
Langmuir. 2014 Jul 8;30(26):7789-97
24921672
Chem Commun (Camb). 2014 Sep 4;50(68):9745-8
25019373
Nano Today. 2013 Oct;8(5):454-460
25419228
Angew Chem Int Ed Engl. 2015 Jan 12;54(3):919-22
25422068
Small. 2015 May 6;11(17):2032-6
25556334
Adv Healthc Mater. 2015 Jun 3;4(8):1236-45
25761648
ACS Nano. 2015;9(4):3540-57
25776964
ACS Nano. 2015 May 26;9(5):5234-45
25859611
Biomaterials. 2015 Jun;53:117-26
25890712
ACS Appl Mater Interfaces. 2015 Jul 15;7(27):14992-9
26094748
ACS Appl Mater Interfaces. 2015 Jul 29;7(29):15735-45
26148139
Biomacromolecules. 2015 Sep 14;16(9):2701-14
26200587
ACS Nano. 2015 Oct 27;9(10):9614-25
26316321
ACS Appl Mater Interfaces. 2015 Sep 23;7(37):20696-706
26325285
ACS Appl Mater Interfaces. 2015 Nov 18;7(45):25014-23
26418578
ACS Appl Mater Interfaces. 2015 Dec 23;7(50):27703-12
26615668
J Mater Chem B. 2016 Jan 7;4(1):32-36
26835125
Sci Rep. 2016 Feb 19;6:21335
26891778
Biomater Sci. 2016 Jul 21;4(7):1062-73
27184106
J Orthop Translat. 2015 Aug 13;3(4):166-177
30035055
Proc Natl Acad Sci U S A. 1975 Mar;72(3):937-40
48253